ROYAL BANK OF CANADA - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$0332
+23.0%
0.00%
Q2 2023$0270
+1073.9%
0.00%
Q3 2022$023
+15.0%
0.00%
Q3 2021$0
-100.0%
20
-98.7%
0.00%
Q2 2021$4,000
-55.6%
1,536
-54.7%
0.00%
Q1 2021$9,000
-86.6%
3,392
-85.6%
0.00%
Q4 2020$67,000
+294.1%
23,574
+193.7%
0.00%
Q3 2020$17,0008,027
+10747.3%
0.00%
Q2 2020$0
-100.0%
74
-47.5%
0.00%
Q1 2020$1,000
-99.7%
141
-99.3%
0.00%
Q4 2019$378,000
+75.0%
20,592
+5.8%
0.00%
Q3 2019$216,000
+9.1%
19,4570.0%0.00%
Q2 2019$198,000
+9800.0%
19,457
+6898.9%
0.00%
Q3 2018$2,000
+100.0%
278
+93.1%
0.00%
Q2 2018$1,000144
+14300.0%
0.00%
Q4 2017$0
-100.0%
1
-99.9%
0.00%
Q3 2017$12,0001,308
+4930.8%
0.00%
Q2 2017$026
+333.3%
0.00%
Q1 2017$060.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders